12:00 AM
 | 
Jun 25, 2012
 |  BC Week In Review  |  Company News  |  Deals

Biocartis, Debiopharm, Immunexpress Group deal

Immunexpress granted Debiopharm and Biocartis exclusive, worldwide rights to co-develop Immunexpress' SeptiCyte Triage for use in emergency and intensive care units to diagnose sepsis and determine...

Read the full 108 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >